Narrow search
Showing 1 - 10 of 446
Cover Image
Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain
Sanchez-de la Rosa, Rainel; Sabater, Eliazar; Casado, … - In: Health economics review 3 (2013) 13, pp. 1-5
Background: Fingolimod is an innovative drug with a significant budget impact in the treatment of MS in Spain. The aim … of this study was to calculate the direct cost comparison of glatiramer acetate and fingolimod for the treatment of … glatiramer acetate and fingolimod, based on a 1-year time horizon. In addition to the pharmacological costs, resource use was …
Persistent link: https://www.econbiz.de/10009755990
Cover Image
Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain
Rosa, Rainel Sanchez-de la; Sabater, Eliazar; Casado, Miguel - In: Health Economics Review 3 (2013) 1, pp. 1-5
Fingolimod therapy requires twice the investment as glatiramer acetate. </AbstractSection> Copyright Sanchez-de la Rosa …
Persistent link: https://www.econbiz.de/10010998799
Cover Image
Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: The Escala study
Sánchez-de la Rosa, Rainel; García-Bujalance, Laura; … - In: Health Economics Review 5 (2015) 30, pp. 1-9
Objective: The Escala Study evidenced that the administration of glatiramer acetate for relapsing-remitting multiple sclerosis improved the spasticity of patients previously treated with interferon-β. However, whether such an improvement was translated into cost savings remained unclear. We...
Persistent link: https://www.econbiz.de/10011599855
Cover Image
Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity : the Escala study
Sánchez-de la Rosa, Rainel; García-Bujalance, Laura; … - In: Health economics review 5 (2015) 30, pp. 1-9
Objective: The Escala Study evidenced that the administration of glatiramer acetate for relapsing-remitting multiple sclerosis improved the spasticity of patients previously treated with interferon-β. However, whether such an improvement was translated into cost savings remained unclear. We...
Persistent link: https://www.econbiz.de/10011472089
Cover Image
Management of Relapsing-Remitting Multiple Sclerosis: Defining the Role of Subcutaneous Recombinant Interferon-beta-1a (Rebif(R)) Use of a tradename is for product identification p...
Lyseng-Williamson, Katherine A.; Plosker, Greg L. - In: Disease Management and Health Outcomes 10 (2002) 5, pp. 307-325
Multiple sclerosis (MS) is a chronic neurological disease of adults that affects over 1 million people worldwide. Relapsing-remitting MS, characterized by acute attacks (relapses) followed by complete or partial remissions, is the most common type of MS at disease onset. Over time, most patients...
Persistent link: https://www.econbiz.de/10005590214
Cover Image
Economic evaluation of biological invasions: A survey
Born, Wanda; Rauschmayer, Felix; Bräuer, Ingo - 2004
Invasive species are one of the main reasons for the loss of biodiversity. Therefore, national strategies are developed to deal with biological invasions. Economic evaluation as a tool of policy advice has to take into account three challenges: (1) reflecting ecological knowledge, which is...
Persistent link: https://www.econbiz.de/10010304537
Cover Image
Economic evaluation of interventions which aim to prevent smoking relapse: Systematic review and critical appraisal
Oyewumi, Kemi-Rotimi - 2014
Aim: To carry out a systematic review of studies that have conducted economic evaluations on smoking relapse prevention interventions by critically appraising the quality of the methodology. Methods: All relevant articles were identified by searching three electronic databases MEDLINE, EMBASE,...
Persistent link: https://www.econbiz.de/10011335884
Cover Image
On the modelling and forecasting multivariate realized volatility: Generalized Heterogeneous Autoregressive (GHAR) model
Baruník, Jozef; Čech, František - 2014
We introduce a methodology for dynamic modelling and forecasting of realized covariance matrices based on generalization of the heterogeneous autoregressive model (HAR) for realized volatility. Multivariate extensions of popular HAR framework leave substantial information unmodeled in residuals....
Persistent link: https://www.econbiz.de/10011340631
Cover Image
Impactos ambientais e econômicos dos veículos elétricos e híbridos plug-in: Uma revisão da literatura
Vonbun, Christian - 2015
This paper presents a brief literature review concerning the costs and benefits of electric vehicles and hybrid electric vehicles, highlighting their advantages in terms of greenhouse gas emissions reductions. Even though electric and electro-hybrid vehicles must still overcome many cultural and...
Persistent link: https://www.econbiz.de/10011372243
Cover Image
Analyse der Wirtschaftlichkeit der Kleingruppen- und Volierenhaltung bei Legehennen
Thobe, Petra; Haxsen, Gerhard - 2013
Nach dem Verbot der konventionellen Käfighaltung in Deutschland stellte sich die Frage nach der Wirtschaftlichkeit von artgerechten alternativen Haltungssystemen. Über die Kleingruppenhaltung, welche relativ neu ist und wieder zur Debatte steht, liegen kaum praxisnahe Informationen vor. Diese...
Persistent link: https://www.econbiz.de/10010326559